Hyderabad-based Natco Pharma has sought permission from drug major Pfizer to sell discounted copies of its HIV drug. In an interview with CNBC-TV18, Bhaskar Narayana, Finance Director & CFO, Natco Pharma threw light on the development and spoke on the company's business plans going forward.
first published: Jan 10, 2011 03:54 pm
A collection of the most-viewed Moneycontrol videos.
Tata Capital's Mega Rs 15,500 Cr IPO Kicks Off| Management On Future Outlook| IPO Watch Live
Live: Big IPOs, Q2 earnings season: Markets enter action-packed week | Opening Bell
The 23-Year-Old Struggling It Out As A Real Estate Broker | The Tenant
Nifty Poised To Clock Weekly Gains; PSU Banks & Metals Star Performers This Week| Closing Bell Live
